Searchable abstracts of presentations at key conferences in endocrinology

ea0011p485 | Endocrine tumours and neoplasia | ECE2006

Thyroid autoimmunity disorders and breast cancer (BC): absence of morphological autoimmune changes in breast malignant tissue

Giustarini EG , Pinchera AP , Fierabracci PF , Campani DC , Giani CG

Thyroid autoimmunity and BC are strongly related, but the cause of this association is unknown. In BC an increase of lymphoid cell infiltrates may be detected very early during tumor development. BC cells share some antigenic properties similar to those detected in thyroid tissue, as NIS and peroxidase activity and it is possible that in patients with BC and thyroid autoimmunity, should be present serum immunoglobulins reacting with these specific antigenes.<p class="abste...

ea0011p235 | Cytokines and growth factors | ECE2006

IGF II protein expression in breast cancer. Relationship with the most important predictive parameters in breast malignancy

Giustarini EG , Pinchera AP , Campani DC , Fierabracci PF , Cullen KC , Giani CG

Recent in situ hybridization data showed high content of IGF-II mRNA in the stroma of breast cancer. The aim of this study was to examine the expression of IGF-II protein and its relationship with several prognostic parameters in 75 ductal infiltrating carcinoma (DIC) of the breast.The tissue sections were evaluated for IGF II protein, proliferating activity, ER, PR, p53, P21 oncogene expression using immunohistochemical procedures. The amoumt of ...

ea0011p827 | Thyroid | ECE2006

Favourable outcome of Graves’ ophthalmopathy (GO) after glucocorticoids (GC) in patients treated with total thyroid ablation (TTA): results of a randomized clinical trial

Menconi FM , Marinò MM , Bartalena LB , Rocchi RR , Nardi MN , Pinchera AP , Marcocci CM

Whether TTA affects GO remains to be established. Here we studied the effects of TTA in 90 patients with mild-moderate GO randomized into 3 groups of thyroid treatment: MMI (methimazole), TX [near-total thyroidectomy (NTTX)], TTA (NTTX plus 131-I). Patients were treated with ivGC and evaluated at 3 and 9 mo. GO was considered improved or worsened when at least 2 of the following criteria changed, either positively or negatively: i) proptosis and/or eyelid width by at least 2 m...

ea0011p685 | Reproduction | ECE2006

Serum levels of PSA do not change in healthy pre-menopausal and in menopausal women, but are increased in subjects with polycystic ovary syndrome (PCOS)

Alessandro Burelli AB , Elisabetta Rineladi ER , Rossana Cionini RC , Elena Benelli EB , Aldo Pinchera AP , Enrico Pucci EP

Background/aims: Prostatic specific antigen (PSA) is the best prostatic tumor marker in man; Recently PSA has been detected in a variety of tissues and fluids in women and is considered a marker of hyperandrogenism. However no precise information are avaible about the physiology of PSA in females. The goal of this study was to assess serum concentrations of PSA in healthy pre-menopausal women (healthy pre-menopausal group) and menopausal women (menopause group) and compare the...